Silence Therapeutics (SLN) Free Cash Flow (2024 - 2026)
Silence Therapeutics (SLN) posted Free Cash Flow of -$15.6 million for Q1 2026, up 9.89% sequentially from -$17.3 million in Q4 2025, and down 26.72% YoY from -$21.3 million in Q1 2025.
Silence Therapeutics (SLN) Free Cash Flow (2024 - 2026) Analysis & Trends
Silence Therapeutics has reported Free Cash Flow for 3 years, with the latest figure at -$15.6 million in Q1 2026.
- Quarterly Free Cash Flow fell 26.72% year-over-year to -$15.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$65.6 million (up 7.57% YoY) and the FY2025 annual result came in at -$62.4 million, up 8.1% from the prior year.
- Free Cash Flow improved to -$15.6 million in Q1 2026 per SLN's latest filing, from -$17.3 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$5.5 million in Q2 2024 and troughed at -$28.2 million in Q4 2024.
- A 3-year average of -$16.2 million and a median of -$15.6 million in 2026 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 56.12% in 2025, down 296.31% in 2025.
- Over 3 years, Free Cash Flow stood at -$28.2 million in 2024, then soared by 38.7% to -$17.3 million in 2025, then climbed by 9.89% to -$15.6 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$15.6 million, -$17.3 million, and -$11.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Silence Therapeutics | 648.22 Mn | 576.12 Mn | - | 1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.50 Mn |
| Jun 30, 2026 | 1.50 Mn |
| Mar 31, 2026 | -15.60 Mn |
| Mar 31, 2026 | -15.60 Mn |
| Dec 31, 2025 | -17.32 Mn |
| Dec 31, 2025 | -17.32 Mn |
| Sep 30, 2025 | -10.95 Mn |
| Sep 30, 2025 | -10.95 Mn |
| Jun 30, 2025 | -21.77 Mn |
| Jun 30, 2025 | -21.77 Mn |
| Mar 31, 2025 | -12.31 Mn |
| Mar 31, 2025 | -12.31 Mn |
| Dec 31, 2024 | -28.25 Mn |
| Dec 31, 2024 | -28.25 Mn |
| Sep 30, 2024 | -24.96 Mn |
| Sep 30, 2024 | -24.96 Mn |
| Jun 30, 2024 | -5.49 Mn |
| Jun 30, 2024 | -5.49 Mn |
| Mar 31, 2024 | -9.14 Mn |
| Mar 31, 2024 | -9.14 Mn |